Science Explorer Back to mapMap

Most cited papers from Fastbase Solutions (Spain)

What are the most cited papers from Fastbase Solutions (Spain)?

The most cited paper from Fastbase Solutions (Spain) is "Immunogenomics of Colorectal Cancer Response to Checkpoint Blockade: Analysis of the KEYNOTE 177 Trial and Validation Cohorts" (Michele Bortolomeazzi et al., 2021), with 153 citations. Next come "Functional Engagement of the PD-1/PD-L1 Complex But Not PD-L1 Expression Is Highly Predictive of Patient Response to Immunotherapy in Non–Small-Cell Lung Cancer" (84) and "High PD-1/PD-L1 Checkpoint Interaction Infers Tumor Selection and Therapeutic Sensitivity to Anti-PD-1/PD-L1 Treatment" (49).

Showing 12 of 12 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Immunogenomics of Colorectal Cancer Response to Checkpoint Blockade: Analysis of the KEYNOTE 177 Trial and Validation Cohorts Michele Bortolomeazzi et al. · Gastroenterology Open access 28 Jun 2021 153
2 Functional Engagement of the PD-1/PD-L1 Complex But Not PD-L1 Expression Is Highly Predictive of Patient Response to Immunotherapy in Non–Small-Cell Lung Cancer Lissete Sánchez‐Magraner et al. · Journal of Clinical Oncology Open access 23 Feb 2023 84
3 High PD-1/PD-L1 Checkpoint Interaction Infers Tumor Selection and Therapeutic Sensitivity to Anti-PD-1/PD-L1 Treatment Lissete Sánchez‐Magraner, James Miles, Claire L. Baker et al. · Cancer Research Open access 27 Aug 2020 49
4 Quantification of PD-1/PD-L1 Interaction between Membranes from PBMCs and Melanoma Samples Using Cell Membrane Microarray and Time-Resolved Förster Resonance Energy Transfer Lissete Sánchez‐Magraner, Miguel de la Fuente, Charles Hall Evans et al. · Analytica—A Journal of Analytical Chemistry and Chemical Analysis Open access 13 Oct 2021 10
5 Quantification of biomarker functionality predicts patient outcomes Banafshé Larijani, James Miles, Stephen Geoffrey Ward et al. · British Journal of Cancer Open access 15 Mar 2021 9
6 The fusion of quantitative molecular proteomics and immune‐oncology : a step towards precision medicine in cancer therapeutics James Miles, Stephen Geoffrey Ward, Banafshé Larijani · FEBS Letters Open access 25 Aug 2022 7
7 Blockverse: A Cloud Blockchain-based Platform for Tracking in Affiliate Systems. Alejandro Baldominos Gómez, J. L. López Sánchez, M. Acevedo-Aguilar · International Journal of Interactive Multimedia and Artificial Intelligence Open access 26 Aug 2020 6
8 Immunogenomic profile of colorectal cancer response to immune checkpoint blockade Michele Bortolomeazzi et al. · bioRxiv (Cold Spring Harbor Laboratory) PreprintOpen access 15 Dec 2020 2
9 Simultaneous Quantification of Multiple Immune Checkpoint Interactions in Melanoma Cristina Cacho-Navas, Laura Camacho, Jon Agüero et al. · Journal of Clinical Medicine Open access 23 Jul 2026 1
10 Multiplexed FRET-FLIM Profiling of Immune Checkpoint Interactions Predicts Response to Atezolizumab in Urothelial Carcinoma Laura Camacho, Cristina Cacho-Navas, Jon Agüero et al. · medRxiv Preprint 3 Sep 2026 0
11 Immunogenomics of colorectal cancer response to immune checkpoint blockade: TCRseq Michele Bortolomeazzi, Mohamed Reda Keddar, Lucia Montorsi et al. · Zenodo (CERN European Organization for Nuclear Research) Open access 21 May 2020 0
12 Immune-checkpoint engagement as predictive biomarkers in clear cell renal cell carcinoma and melanoma Lissete Sánchez‐Magraner, James Miles, Claire Baker et al. · medRxiv PreprintOpen access 16 Jan 2020 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.